78 – Impaired Glucose Regulation and Neuropathy

作者: James W. Russell , A.G. Smith , J.R. Singleton

DOI: 10.1016/B978-012088592-3/50080-3

关键词:

摘要: Type 2 diabetes mellitus (T2DM) and impaired glucose tolerance (IGT) affects a considerably larger, but unknown, population group. The development of peripheral neuropathy is the most common complication T2DM. Several observational studies indicate that IGT fasting are also associated with neuropathy. This chapter addresses spectrum regulation (IGR), pathophysiology IGR neuropathy, clinical presentation's relationship to physiology Definitions for each these disorders based on venous glucose, or values following an oral test. constitutes metabolic can result in There several pathways injury diabetic nervous system include dysregulation induced by syndrome, oxidative stress, failure nitric oxide (NO) regulation, activation advanced glycation end-products (AGE), dysfunction certain key signaling pathways. Modulation NO may have detrimental effects endothelial function neuronal survival. Reactive oxygen species (ROS) alter mitochondrial function, protein, DNA structure; interfere pathways; deplete antioxidant defenses. AGE formation reactive activated and, turn, regulate signal transduction

参考文章(19)
James W. Russell, Rita M. Cowell, Eva L. Feldman, Neuronal and Schwann Cell Death in Diabetic Neuropathy Humana Press. pp. 113- 132 ,(2007) , 10.1007/978-1-59745-311-0_7
Andreas Wellmer, Vijay Peter Misra, Mohammad K. Sharief, Peter G. Kopelman, Praveen Anand, A double‐blind placebo‐controlled clinical trial of recombinant human brain‐derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy Journal of The Peripheral Nervous System. ,vol. 6, pp. 204- 210 ,(2001) , 10.1046/J.1529-8027.2001.01019.X
S Keinänen-Kiukaanniemi, Liisa Hiltunen, E Läärä, Changes in glucose tolerance during three years' follow-up in an elderly population Public Health. ,vol. 113, pp. 181- 184 ,(1999) , 10.1038/SJ.PH.1900553
Rita M. Cowell, James W. Russell, Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy. Journal of Investigative Medicine. ,vol. 52, pp. 33- 44 ,(2004) , 10.1136/JIM-52-01-24
Aaron I Vinik, Vera Bril, Peter Kempler, William J Litchy, Solomon Tesfaye, Karen L Price, Edward J Bastyr III, MBBQ Study Group, Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial Clinical Therapeutics. ,vol. 27, pp. 1164- 1180 ,(2005) , 10.1016/J.CLINTHERA.2005.08.001
James W. Russell, Kelli A. Sullivan, Anthony J. Windebank, David N. Herrmann, Eva L. Feldman, NEURONS UNDERGO APOPTOSIS IN ANIMAL AND CELL CULTURE MODELS OF DIABETES Neurobiology of Disease. ,vol. 6, pp. 347- 363 ,(1999) , 10.1006/NBDI.1999.0254
J. R. Singleton, A. G. Smith, J. W. Russell, E. L. Feldman, Microvascular Complications of Impaired Glucose Tolerance Diabetes. ,vol. 52, pp. 2867- 2873 ,(2003) , 10.2337/DIABETES.52.12.2867
Alison Berent-Spillson, Amanda M. Robinson, David Golovoy, Barbara Slusher, Camilo Rojas, James W. Russell, Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3 Journal of Neurochemistry. ,vol. 89, pp. 90- 99 ,(2004) , 10.1111/J.1471-4159.2003.02321.X
K.-M. Haslbeck, E. Schleicher, A. Bierhaus, P. Nawroth, M. Haslbeck, B. Neundörfer, D. Heuss, The AGE/RAGE/NF-κB Pathway May Contribute to the Pathogenesis of Polyneuropathy in Impaired Glucose Tolerance (IGT) Experimental and Clinical Endocrinology & Diabetes. ,vol. 113, pp. 288- 291 ,(2005) , 10.1055/S-2005-865600
J. Lindstrom, A. Louheranta, M. Mannelin, M. Rastas, V. Salminen, J. Eriksson, M. Uusitupa, J. Tuomilehto, The Finnish Diabetes Prevention Study (DPS) Lifestyle intervention and 3-year results on diet and physical activity Diabetes Care. ,vol. 26, pp. 3230- 3236 ,(2003) , 10.2337/DIACARE.26.12.3230